Meningococcal Group B Vaccine
Introduction
Meningococcal group B (MenB) bacteria causes serious life-threatening infections worldwide, including meningitis and sepsis. There are 12 groups of meningococcal bacteria, and MenB is responsible for 90% of the meningococcal infections in the UK.
MenB vaccine protection
There are many different strains of MenB bacteria around the world and some tests say that the MenB vaccine protects almost 90% of this bacteria.
Our trained and competent pharmacist can administer the meningococcal group B vaccine, under a patient group direction. It is for patients aged 2 months, or older presenting for immunisation against the invasive meningococcal disease caused by Neisseria meningitidis group B
How does the MenB vaccine work?
The vaccine is made from 3 major proteins which are also found on the surface of most meningococcal bacteria, combined with the outer membrane of 1 MenB strain. They work together to stimulate the immune system and to protect against any exposure to future meningococcal bacteria that may occur.
Please click HERE to book an appointment with our trained pharmacist.
| Consultation required? |
Yes |
|---|

Reviews
There are no reviews yet.